PubRank

Ajay Bhatia

Author PubWeight™ 18.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Propionibacterium acnes types I and II represent phylogenetically distinct groups. J Clin Microbiol 2005 1.75
2 Identification of concomitant infection with Chlamydia trachomatis IncA-negative mutant and wild-type strains by genomic, transcriptional, and biological characterizations. Infect Immun 2008 1.48
3 Optimized subunit vaccine protects against experimental leishmaniasis. Vaccine 2009 1.39
4 CAMP factor homologues in Propionibacterium acnes: a new protein family differentially expressed by types I and II. Microbiology 2005 1.28
5 Design, development and evaluation of rK28-based point-of-care tests for improving rapid diagnosis of visceral leishmaniasis. PLoS Negl Trop Dis 2010 1.28
6 Applying TLR synergy in immunotherapy: implications in cutaneous leishmaniasis. J Immunol 2010 1.14
7 Lyme disease in the United Kingdom. Postgrad Med J 2013 1.08
8 Variable expression of immunoreactive surface proteins of Propionibacterium acnes. Microbiology 2006 1.05
9 KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis. Clin Vaccine Immunol 2011 1.01
10 Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis. FEMS Immunol Med Microbiol 2009 0.99
11 Distinct antigen recognition pattern during zoonotic visceral leishmaniasis in humans and dogs. Vet Parasitol 2008 0.97
12 Selection of antigens and development of prototype tests for point-of-care leprosy diagnosis. Clin Vaccine Immunol 2008 0.96
13 KSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqi. PLoS Negl Trop Dis 2012 0.91
14 Leishmania infantum sterol 24-c-methyltransferase formulated with MPL-SE induces cross-protection against L. major infection. Vaccine 2009 0.90
15 Tumor necrosis factor (TNF) can paradoxically increase on etanercept treatment, occasionally contributing to TNF-mediated disease. J Rheumatol 2007 0.87
16 High levels of soluble CD40 ligand and matrix metalloproteinase-9 in serum are associated with favorable clinical evolution in human visceral leishmaniasis. BMC Infect Dis 2013 0.80
17 Validation of a body mass index nomogram for children as an obesity screening tool in young children. Clin Pediatr (Phila) 2006 0.78
18 Consideration of use of neuraminidase inhibitors such as oseltamivir and zanamivir in IgA nephropathy. Kidney Int 2005 0.75